3Culleton BF,Larson MG,Kannel KG,et al.Serum uric acid and risk for cardiovascular disease and death:the Framingham Heart Study[J].Ann Intem Med,1999;131(15):7-13.
4Fang J,Alderman MH,Fermen H.Serum uric acid and cardiovascular mortality the NHANES 1 epidemiologic follow-up study,1971-1992[J].JAMA,2000;283(18):2404-10.
5党爱民 刘国仗.高尿酸血症与心血管事件的关系[N].中国医学论坛报,2003-9-18(12).
6Tsutamoto T,Wada A,Maeda K.Angiotensin 2 type 1 receptor antagonist decrease plas ma levels of tumor necrosis factor alpha,interleckin 6 and stuble adhesion molecules in patients with chronic heart failure[J].J Am Coll Cardiol,2000,35:714-6.
二级参考文献6
1Leyva F,Ankel S,Swan JW,et al. Serum uric acid as an index of inpaired oxidative metabolism in chronic heart failure. Eur Heart J, 1997,18:858.
2Collcion BF, -Larson MG,Kannel WB, et al. Serum uric acid and risk for cardiovascular disease and death. The Framingham Heart Study. Am intren Med,1999,131:7.
3Brand FN, Mc Gee DL, Kanncl WB, et al. Original Coulrib ulions of hyperuriennia as a risk factor of coronary heart disease. The Framingham Study. Am J Epidemial, 1985,121 : 11.
4Freedman DS, Williamson DF, Genler EW, et al. Relation of serum acid to motality and ischemic heart disease. The NILANESL Epidemiologic Follow - up study. Am J Epidemial, 1995,141:637.
5Wannamethee SG,Shaper AG,Whincup PH. Serum uratic and the risk of major coronary heart disease events. Heart, 1997,78:147.
